Aditxt names Jeffrey Busch interim CEO as Amro Albanna resigns

Aditxt, Inc.

Aditxt, Inc.

ADTX

0.00
  • Aditxt appointed Jeffrey M. Busch interim CEO effective May 31, 2026, keeping his role as CEO of subsidiary Ignite Proteomics.
  • Outgoing CEO Amro Albanna resigned as CEO, left the board, stepped down from all positions across the company’s subsidiaries.
  • Busch previously founded and led Global Medical REIT, now Chiron Real Estate, building it to over USD 1 billion enterprise value.
  • Management shift signals an accelerated commercialization push centered on Ignite’s precision oncology diagnostics platform.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ADiTx Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202606010815BIZWIRE_USPR_____20260601_BW699250) on June 01, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.